Published in Clin Exp Immunol on July 01, 1975
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol (1975) 0.89
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels. Clin Exp Immunol (1975) 0.84
Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81
The evidence justifying immunosuppression therapy in multiple sclerosis. Proc R Soc Med (1977) 0.75
Prolonged azathioprine treatment of non-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (1979) 0.75
The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report. Neurology (1970) 2.56
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
A tissue-culture approach to demyelinative disorders. Natl Cancer Inst Monogr (1963) 1.46
Therapeutic trial of immunosuppressive agents in multiple sclerosis. Neurology (1972) 1.18
Long-term treatment of multiple sclerosis with azathioprine. J Neurol Neurosurg Psychiatry (1973) 1.09
Intensive immunosuppression in the treatment of multiple sclerosis. Lancet (1974) 1.04
In vitro delayed (cellular) hypersensitivity in multiple sclerosis to central nervous system antigens. Int Arch Allergy Appl Immunol (1970) 1.03
Therapeutic trial of Imuran (azathioprine) in multiple sclerosis. Acta Neurol Scand (1971) 0.92
Intensive immunosuppression in patients with disseminated sclerosis. III. Lymphocyte response in vitro. Clin Exp Immunol (1975) 0.89
Effect of 'maximum immune suppression' with thoracic duct drainage, ALG, azathioprine and cortisone in some neurological disorders. Proc R Soc Med (1972) 0.89
Evaluation of antithymocyte globulin in acute relapses of multiple sclerosis. Neurology (1974) 0.88
Effects of cortisol and antilymphocyte serum on lymphoid populations. Ciba Found Study Group (1970) 0.84
Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis. Neurology (1973) 0.84
[Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis]. Presse Med (1969) 0.84
Intensive immunosuppression in patients with disseminated sclerosis. II. Tolerance to equine IgG and effect on immunoglobulin and complement levels. Clin Exp Immunol (1975) 0.84
The treatment of multiple sclerosis. Med Clin North Am (1972) 0.80
Immunological tolerance induced in adult dogs by small amounts of horse IgG. Transplantation (1969) 0.79
Multiple sclerosis: a review. Br Med J (1973) 0.79
The fate of skin homografts in man. J Anat (1943) 17.30
Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56
Uncertainty in predictions of the climate response to rising levels of greenhouse gases. Nature (2005) 7.46
Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer (1999) 6.86
Application and results of the Manchester Short Assessment of Quality of Life (MANSA). Int J Soc Psychiatry (1999) 3.95
Rate of regeneration of peripheral nerves in man. J Physiol (1943) 3.02
The structure of coxsackievirus B3 at 3.5 A resolution. Structure (1995) 2.73
The distribution of 51Cr-labeled lymphocytes into antigen-stimulated mice. Lymphocyte trapping. J Exp Med (1971) 2.60
Parasitological review. Nippostrongylus brasiliensis: a review of immunity and host-parasite relationship in the rat. Exp Parasitol (1971) 2.42
THE CHEMICAL INHIBITION OF FIBRE REGENERATION AND NEUROMA FORMATION IN PERIPHERAL NERVES. J Neurol Psychiatry (1942) 2.38
Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. J Biol Chem (1998) 2.32
Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31
Immuno-regulatory role of spleen localizing thymocytes. J Immunol (1974) 2.27
Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity (2001) 2.23
Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci (1982) 2.14
Segregation of lymphocyte populations through differential migration. Nature (1969) 2.09
Immunochemical study of antigenic specificity in delayed hypersensitivity. V. Immunization with monovalent low molecular weight conjugates. J Exp Med (1966) 2.06
A collagen disorder of the nervous system presenting as multiple sclerosis. Brain (1972) 2.00
Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96
Rejection of skin allografts by radiation chimaeras: selective gene action in the specification of cell surface structure. Nature (1970) 1.95
The transformation in vitro of peripheral lymphocytes of some laboratory animals. Immunology (1965) 1.91
The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis (2006) 1.87
Role of activated macrophages and antibody in inhibition and enhancement of tumour growth in rats. Lancet (1971) 1.86
Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) (2005) 1.84
Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital. J Gen Microbiol (1980) 1.84
The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76
Motor vehicle crash characteristics and medical outcomes among older drivers in Utah, 1992-1995. Ann Emerg Med (2000) 1.75
Reaginic antibodies and immunity to Nippostrongylus brasiliensis in the rat. II. Some properties of the antibodies and antigens. Immunology (1967) 1.71
Passive protection with cells or antiserum against Nippostronglylus brasiliensis in the rat. Parasitology (1968) 1.71
Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology (2010) 1.69
A hospital outbreak of antibiotic-resistant Acinetobacter anitratus: epidemiology and control. J Hosp Infect (1980) 1.69
The distribution of chromium 51-labelled lymphoid cells in the mouse. A survey of anatomical compartments. Cell Immunol (1970) 1.67
Antigenicity in mice of antilymphocyte gamma-globulin. Nature (1967) 1.67
Epidemiology of single and multiple species of helminth infections among school children in Busia District, Kenya. East Afr Med J (2000) 1.62
Connexin43 null mice reveal that astrocytes express multiple connexins. Brain Res Brain Res Rev (2000) 1.61
Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61
Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet (1999) 1.59
A note on the specificity of the corneal epithelium. J Anat (1950) 1.59
A simple technique for harvesting lymphocytes cultured in Terasaki plates. J Immunol Methods (1979) 1.58
Reduced prevalence of impaired glucose tolerance and no change in prevalence of diabetes despite increasing BMI among Aboriginal people from a group of remote homeland communities. Diabetes Care (2000) 1.58
Cellular immunity and the homograft reaction. Br Med Bull (1967) 1.54
Acquired immunological tolerance of foreign cells is impaired by recombinant interleukin 2 or vitamin A acetate. Proc Natl Acad Sci U S A (1985) 1.53
Immunologic reactivity in rheumatoid arthritis. Response to mitogens. Arthritis Rheum (1974) 1.52
Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52
Protective immunity to Nippostrongylus brasiliensis: the sequence of events which expels worms from the rat intestine. Immunology (1971) 1.51
Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis (1986) 1.47
'Actively acquired tolerance' of foreign cells. 1953. J Immunol (2010) 1.46
Experimental immune synovitis in the rabbit. Relative roles of cell mediated and humoral immunity. Arthritis Rheum (1975) 1.46
[Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery]. Chirurg (2008) 1.44
Perspectives on stimulating industrial research and development for neglected infectious diseases. Bull World Health Organ (2001) 1.44
The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis. Leukemia (2006) 1.40
Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer. Med J Aust (1998) 1.40
Periplasmic chaperone recognition motif of subunits mediates quaternary interactions in the pilus. EMBO J (1998) 1.40
Survival of skin heterografts under treatment with antilymphocytic serum. Lancet (1968) 1.39
Molecular diagnosis of a Mycobacterium chelonae infection. Pathol Res Pract (2001) 1.39
Clinical trials of antibacterial agents: a practical guide to design and analysis. Statisticians in the Pharmaceutical Industry Working Party. J Antimicrob Chemother (1998) 1.37
The circulating immunoglobulins involved in protective immunity to the intestinal stage of Nippostrongylus brasiliensis in the rat. Immunology (1970) 1.36
Muramic acid is not detectable in Chlamydia psittaci or Chlamydia trachomatis by gas chromatography-mass spectrometry. Infect Immun (1990) 1.36
The use of subcellular fractions to raise anti-lymphocytic serum. Immunology (1968) 1.36
Immunochemical study of antigenic specificity in delayed hypersensitivity. 3. Suppression of hapten-specific delayed hypersensitivity by conjugates of varying size. J Immunol (1965) 1.34
Rat 7S immunoglobulins: characterization of gamma-2- and gamma-1-anti-haptens antibodies. Immunology (1969) 1.34
Quantitative studies on tissue transplantation immunity. IX. Induction of tolerance with antilymphocytic serum. Proc R Soc Lond B Biol Sci (1969) 1.33
Acceptability of peanut butter cookies prepared using mungbean paste as a fat ingredient substitute. J Am Diet Assoc (2001) 1.33
Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31
Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J Med Genet (1999) 1.31
Immunoscintigraphy of colon carcinoma. J Nucl Med (1984) 1.31
Meningitis after Spinal Analgesia. Br Med J (1945) 1.29
Role of the carrier in development of delayed sensitivity to the azophenyl-arsonate group. Nature (1965) 1.27
The cellular origin of the lymphochte trap. Immunology (1974) 1.27
Reexamination of the Three-Dimensional Structure of the Small Subunit of RuBisCo from Higher Plants. Science (1989) 1.27
Characterization of antilymphocytic antibody. Nature (1967) 1.27
Analysis of very late gene expression by Autographa californica nuclear polyhedrosis virus and the further development of multiple expression vectors. J Gen Virol (1990) 1.25
A comparison of the responses of lymphocytes from blood, spleen, thymus and appendix of rabbits of different ages to stimulation "in vitro" with staphylococcal filtrate. Clin Exp Immunol (1969) 1.25
Effects of lymphoid depletion on the distribution of 51Cr-labeled lymph node cells in mice. Transplantation (1971) 1.23
Immunity to Plasmodium berghei in rats: maximum levels of protective antibody activity are associated with eradication of the infection. Parasitology (1972) 1.22
The interaction of normal lymphocytes and cells from lymphoid cell lines. I. The nature of the activation process. Immunology (1970) 1.22
Immune complexes in early arthritis. L Detection of immune complexes before rheumatoid arthritis is definite. Clin Exp Immunol (1981) 1.21
T-cell-mediated enhancement of host-versus-graft reactivity in mice fed a diet enriched in vitamin A acetate. Nature (1983) 1.20
Homing of specifically sensitized lymphocytes to allografts of skin. Cell Immunol (1972) 1.20
Immunochemical study of antigenic specificity in delayed hypersensitivity. IV. The production of unresponsiveness to delayed hypersensitivity with a single antigenic determinant. J Exp Med (1965) 1.19
Immunity in the parasitic relationship between helminths and hosts. Prog Allergy (1973) 1.19
Isolation of immune complexes and characterisation of their constituent antigens and antibodies in some human diseases: a review. J Immunol Methods (1981) 1.17
Androgens regulate bone resorption activity of isolated osteoclasts in vitro. Proc Natl Acad Sci U S A (1999) 1.17
The isolation of immune complexes containing IgM rheumatoid factor and recovery of IgG rheumatoid factor from the complexes. J Immunol Methods (1980) 1.14
The mechanism of action of anti-lymphocyte serum. Studies of antibody eluate. J Exp Med (1969) 1.13
Structure determination of coxsackievirus B3 to 3.5 A resolution. Acta Crystallogr D Biol Crystallogr (1995) 1.13
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxine. Lancet (1984) 1.13
Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol (1999) 1.12
'Actively acquired tolerance' of foreign cells. 1953. Transplantation (2003) 1.12
Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH. Int J Cancer (2000) 1.11
Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate. Proc Natl Acad Sci U S A (1983) 1.10
Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study. J Clin Pathol (2009) 1.10
Toxicity of Sulphonamide Drugs to Cells in Vitro. Br Med J (1941) 1.10
2.2 A resolution structure of the amino-terminal half of HIV-1 reverse transcriptase (fingers and palm subdomains). Structure (1994) 1.09
Reaginic antibodies and immunity to Nippostrongylus brasiliensis in the rat. I. The effect of thymectomy, neonatal infections and splenectomy. Parasitology (1967) 1.09
Double-blind controlled trial of immunosuppression in the treatment of multiple sclerosis: final report. Lancet (1982) 1.09
Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats. J Card Fail (1999) 1.08